Bausch Health Companies Inc. (BHC) Financials
BHC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 24.8 billion | 25.6 billion |
| March 31, 2026 | 24.5 billion | 25.6 billion |
| Dec. 31, 2025 | 26.3 billion | 25.9 billion |
| Sept. 30, 2025 | 26.8 billion | 26.4 billion |
BHC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 593.0 million | 54.0 million |
| March 31, 2026 | 83.0 million | 52.0 million |
| Dec. 31, 2025 | 402.5 million | 84.0 million |
| Sept. 30, 2025 | 314.0 million | 43.0 million |
BHC Net Income
No data available :(
BHC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.8 billion | 19.9 billion | 38.0 million |
| March 31, 2026 | 1.3 billion | 19.9 billion | 31.0 million |
| Dec. 31, 2025 | 1.3 billion | 20.7 billion | 189.7 million |
| Sept. 30, 2025 | 1.3 billion | 20.4 billion | - |
BHC Shares Outstanding
BHC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 77.0 million | 173.0 million | 907.0 million | - |
| March 31, 2026 | 147.0 million | 163.0 million | 861.0 million | - |
| Dec. 31, 2025 | 93.4 million | 51.0 million | 882.0 million | - |
| Sept. 30, 2025 | 91.0 million | 247.0 million | 795.0 million | - |
BHC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 2.9 billion | 772.0 million |
| March 31, 2026 | 2.5 billion | 738.0 million |
| Dec. 31, 2025 | 2.8 billion | 798.0 million |
| Sept. 30, 2025 | 2.7 billion | 750.0 million |
BHC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BHC
Price: $5.80
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.94 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 1.8 million
Market Capitalization: 2.5 billion